This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mary S. Brady, MD; Daniel G. Coit, MD

Arch Dermatol. 1997;133(8):1014-1020.

Abstract
The surgical treatment of patients with cutaneous melanoma has been revolutionized by the development of lymphatic mapping and sentinel lymph node biopsy. This procedure involves injecting a radioactive tracer at the site of the primary melanoma (before wide excision); the tracer then travels via the lymphatics to the first draining or sentinel lymph node. The node is removed and evaluated for the presence of metastatic melanoma. In this way, patients who are most likely to benefit can be selected for regional lymphadenectomy. In addition, accurate and minimally invasive staging allows the surgeon to identify patients who may benefit from adjuvant and investigational immunotherapy. We review the development of lymphatic mapping, the technical details related to the procedure itself, and the published clinical studies using this new procedure. In addition, we discuss the controversial issues that have been raised with the introduction of sentinel lymph node biopsy. Arch Dermatol. 1997;133:1014-1020

Author Affiliations
From the Department of Surgery, Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, NY.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preoperative Melanoma Thickness Determination by 20-MHz Sonography and Digital Videomicroscopy in Combination
Pellacani and Seidenari
Arch Dermatol 2003;139:293-298.
ABSTRACT | FULL TEXT  

Melastatin Expression and Prognosis in Cutaneous Malignant Melanoma
Duncan et al.
JCO 2001;19:568-576.
ABSTRACT | FULL TEXT